Table 2.
Medications and operative details (by procedure)
| Antibiotics pre-surgery | |
| Ciprofloxacin | 10 (12.3%) |
| Augmentin | 7 (8.6%) |
| Other | 3 (3.7%) |
| None | 61 (75.3%) |
| Antibiotics post-surgery | |
| Ciprofloxacin | 11 (13.6%) |
| Augmentin | 8 (9.9%) |
| Other | 4 (4.9%) |
| None | 58 (71.6%) |
| Biologics (CD only) | |
| Ustekinumab | 29 (35.8%) |
| Infliximab | 10 (12.3%) |
| Adalimumab | 8 (9.9%) |
| Vedolizumab | 4 (4.9%) |
| Other | 2 (2.5%) |
| None | 3 (3.7%) |
| Immunomodulators (CD only) | |
| Azathioprine | 18 (22.2%) |
| Methotrexate | 10 (12.3%) |
| Mercaptopurine | 1 (1.2%) |
| None | 27 (33.3%) |
| Donor site | |
| Abdomen | 51 (63%) |
| Abdomen + other | 10 (12.3%) |
| Extremity | 15 (18.5%) |
| Other | 5 (6.2%) |
| Intervention | |
| Stem cell | 55 (67.9%) |
| Stem cell + plug | 24 (29.6%) |
| Stem cell + other | 2 (2.5%) |